Eva Domingo-Domenech, MD on ADCETRIS: Why Are Targeted Therapies Important in Treating sALCL?

Eva Domingo-Domenech, MD on ADCETRIS: Why Are Targeted Therapies Important in Treating sALCL?

Cancer-News

1 month
17 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Eva Domingo-Domenech, MD of Institut Català d'Oncologia – Hospitalet discusses ADCETRIS for Treatment of Adult Patients with Previously Untreated sALCL: Why are targeted therapies important in treating sALCL?
Up Next Autoplay